Open an Account
search icon
3
NOTIFICATIONS
Best Algo trading app in India
Bigul

Our CMD, Dr. A. Velumani's Participation At A Conference On 30-05-2017.

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that our Chairman & Managing Director, Dr. A. Velumani, will be attending an investor conference on 30th May, 2017 at Hotel Sofitel, BKC, Mumbai. The conference is arranged by Phillip Capital and Dr. A. Velumani will be having interactive session with investors. It would be an open session and would be participated by global/...
22-05-2017
Bigul

Presentation On FY 2017 Results

 We are forwarding copy of Presentation and Media Release on Annual Results of our company for the year ended 31-03-2017. Please note that these two documents have only been uploaded in our website, and have not been distributed or advertised in newspapers or otherwise publicised.
11-05-2017
Bigul

Conference Call Post Declaration Of Annual Financial Results For The Year Ended 31-03-2017

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a conference call for the Indian and overseas analysts is arranged by our management to discuss the Company's financial results for Quarter / whole year ended March 31, 2017, on Thursday, May 11, 2017 at 4.00 P.M. local time. Dr. Velumani A., Ph.D., CEO, Mr. A. Sundararaju, CFO and Mr. Sachin Salvi, GM-Finance, will represent...
10-05-2017
Bigul

Board recommends Final Dividend

 Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2017, inter alia, have also decided to recommend declaration of final dividend at the rate of Rs. 5.00 (Rupees Five only) per share (50% of the face value of Rs. 10/- each) to the Shareholders for their approval.The Meeting concluded at 8.15 p.m.
10-05-2017
Bigul

Annual report for Thyrocare Technologies Ltd. for FY-2017
10-05-2017
Bigul

Outcome of Board Meeting

 Our Board today approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2017 and have also decided to recommend declaration of final dividend at the rate of Rs. 5.00 per share to the Shareholders for their approval. The Meeting concluded at 8.15 p.m. today, and approved granting of Stock Options to the eligible employees of the Company for the year 2016-17 also. Pursuant to Regulation 33 (3)...
09-05-2017
Bigul

Closure of Trading Window

 A meeting of the Board of Directors will be held on 09-05-2017 inter alia to consider and approve stand-alone and consolidated audited financial results for the quarter/year ended 31-03-2017. Please note that pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015, the trading window of the Company will remain closed for trading in Company's equity shares for Directors / Designated Employees / Connected Persons from...
02-05-2017
Bigul

Board Meeting On 09-05-2017 To Consider And Approve Stand-Alone And Consolidated Financial Results For The Quarter /Year Ended 31-03-2017 And To Consider Granting Of Stock Options For Employees For The Year Ended 31-03-2017.

 Pursuant to Regulation 29 (1) (a) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to intimate that a meeting of our Board of Directors of the Company will be held on Tuesday, the 9th May 2017, at the Corporate Office of the Company, inter alia, to consider and approve Stand-alone and Consolidated Audited Financial Results of the Company for the quarter / financial year ended March 31, 2017 and to consider granting...
02-05-2017
Bigul

Meeting Of Investors With Our Chairman & Managing Director, Dr.A.Velumani During His Visit To UK On 26Th And 27Th April 2017.

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that our Chairman & Managing Director, Dr. A. Velumani, would be visiting London shortly on some other engagement, and during the visit, he would also be meeting various investors, as mentioned in our letter.
22-04-2017
Bigul

Compliance Certification (RTA & Compliance Officer) Under Reg.7(3).

 As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2016 to March 31, 2017 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share...
15-04-2017
Next Page
Close

Let's Open Free Demat Account